Form 4: Arcutis Biotherapeutics Executive Sells Shares to Cover Tax Obligations

Masaru Matsuda, an executive at Arcutis Biotherapeutics, sold 5,015 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• On November 4, 2024, Masaru Matsuda, Senior Vice President, General Counsel, and Corporate Secretary of Arcutis Biotherapeutics, sold 5,015 shares of the company's common stock.
• The sale was executed to satisfy tax withholding obligations associated with the vesting of Matsuda's Restricted Stock Units (RSUs).
• The shares were sold at a weighted average price of $8.6842, with individual transactions ranging from $8.32 to $8.86.
• Following the transaction, Matsuda directly owns 178,273 shares of Arcutis Biotherapeutics.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction to cover tax obligations. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company.

Stakeholder Impact

• The sale of shares by an executive could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect.

Key Dates